Feature Channels: Pharmaceuticals

Filters close

Not for public release

This news release is embargoed until 14-Aug-2023 5:00 PM EDT Released to reporters: 8-Aug-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 14-Aug-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 11-Aug-2023 9:55 AM EDT
UTHealth Houston joins SATURN trial, studying role of statins in recurrent intracerebral hemorrhage
University of Texas Health Science Center at Houston

A clinical trial evaluating the role of statins in the risk of recurrent intracerebral hemorrhage (ICH) in patients presenting with ICH, has opened for enrollment at UTHealth Houston.

Newswise: ASPET Launches Automated Patient-Oriented Problem-Solving Learning Tool
Released: 11-Aug-2023 9:40 AM EDT
ASPET Launches Automated Patient-Oriented Problem-Solving Learning Tool
Federation of American Societies for Experimental Biology (FASEB)

The American Society for Pharmacology and Experimental Therapeutics (ASPET) has automated its Automated Patient-Oriented Problem-Solving (A-POPS) learning tool.

Released: 11-Aug-2023 9:00 AM EDT
GI Multi-Society Statement Regarding GLP-1 Agonists and Endoscopy
American College of Gastroenterology (ACG)

AASLD, ACG, AGA, ASGE and NASPGHAN recognize that the new class of GLP-1 receptor agonist may be associated with delayed gastric emptying and encourage our anesthesiology, endocrinology, and industry partners to work collaboratively with our members to develop the necessary evidence to appropriately inform medication adjustments prior to elective endoscopy.

Released: 10-Aug-2023 4:05 PM EDT
Back to school: MSU experts on health and safety issues for students
Michigan State University

Over 50 million K-12 students across the United States will return to classrooms this month, according to the National Center for Education Statistics. Michigan State University experts provide guidance on how to ensure students are physically and mentally prepared for the new school year.

   
Newswise: A medication used for heart conditions improves the efficacy of current treatments for melanoma
9-Aug-2023 10:00 AM EDT
A medication used for heart conditions improves the efficacy of current treatments for melanoma
Fundació Institut de Recerca Biomèdica (IRB BARCELONA)

A collaborative study undertaken by the Navarrabiomed Biomedical Research Center (Pamplona, Navarre), the Institute of Neurosciences CSIC-UMH (Sant Joan d’Alacant, Valencian Community) and IRB Barcelona (Barcelona, Catalonia) shows that the administration of ranolazine, a drug currently used to treat heart conditions, improves the efficacy of current therapies for melanoma, in mouse models of this disease.

Newswise: Johns Hopkins Researchers Develop Gut-Restricted Drug to Treat IBD
Released: 10-Aug-2023 9:05 AM EDT
Johns Hopkins Researchers Develop Gut-Restricted Drug to Treat IBD
Johns Hopkins Medicine

A new study of mice and lab-grown human colon “organoids” indicates that an experimental drug developed by Johns Hopkins Medicine researchers can substantially reduce symptoms of inflammatory bowel disease (IBD) in pre-clinical models.

Released: 10-Aug-2023 8:05 AM EDT
Rakuten Medical and Hikma Sign Exclusive Licensing Agreement for Alluminox™ Platform Cancer Treatment in the Middle East and North Africa
Rakuten Medical, Inc.

Rakuten Medical, Inc., a global biotechnology company developing and commercializing precision, cell targeting therapies based on its proprietary Alluminox™ platform today announces an exclusive licensing and commercialization agreement with Hikma Pharmaceuticals PLC (Hikma), a multinational pharmaceutical company for the Middle East and North Africa (MENA).

3-Aug-2023 4:00 PM EDT
Long-Term Use of Certain Acid Reflux Drugs Linked to Higher Risk of Dementia
American Academy of Neurology (AAN)

People who take acid reflux medications called proton pump inhibitors for four-and-a-half years or more may have a higher risk of dementia compared to people who do not take these medications, according to new research published in the August 9, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology. This study does not prove that acid reflux drugs cause dementia; it only shows an association.

Released: 9-Aug-2023 11:35 AM EDT
Scientists study how a diabetes drug affects soils
Prairie Research Institute

In a recent study, Illinois Sustainable Technology Center environmental chemist Wei Zheng and colleagues investigated the adsorption of sitagliptin in soils treated with sewage wastewater.

Released: 8-Aug-2023 5:40 PM EDT
How psychedelic drugs affect a rat’s brain
Lund University

Researchers at Lund University have developed a technique for simultaneously measuring electrical signals from 128 areas of the brain in awake rats.

Newswise: Big Data. Bigger Opportunities.
Released: 8-Aug-2023 1:20 PM EDT
Big Data. Bigger Opportunities.
Sanford Burnham Prebys

New and rapidly developing technologies, such as cryo-electron (cryo-EM) and artificial intelligence, are providing the tools to revolutionize biomedical research, but you need scientists who know how to use them

   
Newswise: Chulalongkorn’s Faculty of Pharmaceutical Sciences Presents Plant-Based Biopharmaceutical Research to Combat Cancer Cells in Lab Animals
Released: 8-Aug-2023 8:55 AM EDT
Chulalongkorn’s Faculty of Pharmaceutical Sciences Presents Plant-Based Biopharmaceutical Research to Combat Cancer Cells in Lab Animals
Chulalongkorn University

For the first time in Thailand, lecturers at Chulalongkorn University’s Faculty of Pharmaceutical Sciences have successfully developed antibody from tobacco plants with inhibitory effects on the growth of cancer cells in laboratory animals. This signals hope for access to effective cancer medication and treatment at a lower cost.

   
Newswise: Opioids, Methadone and Babies
Released: 8-Aug-2023 6:05 AM EDT
Opioids, Methadone and Babies
Children's Hospital Los Angeles

A new study led by Lorraine Kelley-Quon, MD, MSHS, pediatric surgeons at Children’s Hospital Los Angeles shows that methadone use in babies after surgery can lead to longer hospital stays.

Released: 7-Aug-2023 5:05 PM EDT
Human antibody that targets carfentanil, fentanyl and related opioids reverses overdose effects in preclinical study
Scripps Research Institute

An antibody in single-chain fragment variable (scFv) format that binds to the powerful opioid carfentanil was shown to reverse signs of carfentanil overdose in preclinical tests conducted by scientists at Scripps Research.

Not for public release

This news release is embargoed until 7-Aug-2023 5:00 PM EDT Released to reporters: 1-Aug-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 7-Aug-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 7-Aug-2023 5:00 PM EDT Released to reporters: 1-Aug-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 7-Aug-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: New Study in JNCCN Highlights Rapid Adoption of Clinical Research Results into Chemotherapy Prescribing Patterns
3-Aug-2023 10:00 AM EDT
New Study in JNCCN Highlights Rapid Adoption of Clinical Research Results into Chemotherapy Prescribing Patterns
National Comprehensive Cancer Network® (NCCN®)

JNCCN study sheds light on a rapid shift in practice evolution by oncologists treating people with colon cancer adjuvantly after primary surgery, following publications from the IDEA collaboration.

Released: 7-Aug-2023 2:25 PM EDT
Increased Risk of Dementia Diagnosis, Benzodiazepine Exposure in Seniors with Anxiety
Saint Louis University Medical Center

Research from Saint Louis University School of Medicine finds that among patients 65 and older, a diagnosis of anxiety was significantly associated with an increased risk of dementia diagnosis, and benzodiazepine exposure was associated with a 28% increased risk of dementia.

Not for public release

This news release is embargoed until 7-Aug-2023 2:05 PM EDT Released to reporters: 7-Aug-2023 2:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 7-Aug-2023 2:05 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 3-Aug-2023 5:05 PM EDT
Deep learning for new protein design
University of Texas at Austin (UT Austin)

The key to understanding proteins — such as those that govern cancer, COVID-19, and other diseases — is quite simple. Identify their chemical structure and find which other proteins can bind to them. But there’s a catch.

   
Released: 3-Aug-2023 4:05 PM EDT
After 7 years, generative AI succeeds in predicting clinical trial outcomes
Insilico Medicine

Since its inception in 2014, Insilico Medicine has developed multiple AI models for predicting the probability of success of clinical trials focusing on Phase II to Phase III transition probabilities.

   
Newswise: Injection of Hope: How Botox Keeps Migraines at Bay
Released: 3-Aug-2023 3:05 PM EDT
Injection of Hope: How Botox Keeps Migraines at Bay
LifeBridge Health

Dr. Santiago Mazuera, head of Sinai Hospital's Headache Clinic, shares how Botox treatments can drastically improve quality of life for those who experience chronic migraines.

Newswise: New Study Explores the Role of Metformin in Ameliorating HMGB1-Mediated Oxidative Stress in Periodontitis
Released: 3-Aug-2023 1:00 PM EDT
New Study Explores the Role of Metformin in Ameliorating HMGB1-Mediated Oxidative Stress in Periodontitis
Chinese Academy of Sciences

A recent study reveals that Metformin, a common drug used to manage Type 2 Diabetes, could offer new hope for treating periodontitis, a chronic inflammatory disease affecting oral tissues. The study explored the effects of Metformin on HMGB1 (High Mobility Group Box 1), an inflammation mediator implicated in oxidative stress during periodontitis.

Newswise: July Research Highlights
Released: 3-Aug-2023 12:05 PM EDT
July Research Highlights
University of Utah Health

Huntsman Cancer Institute investigators find a way to reduce infection after pancreatic surgery, discover the best treatment combination that’s cost effective for prostate cancer patients, and learn lung cancer patients receiving chemotherapy have more emergency department visits. They also found a genetic mutation that makes anemia more likely after chemotherapy, and a non-invasive way to remove brain tumors.

Newswise: Researchers find drugs that reduce infant death may lead to long-term health issues
31-Jul-2023 2:05 PM EDT
Researchers find drugs that reduce infant death may lead to long-term health issues
McMaster University

Corticosteroids are used to increase very preterm infant survival rates and reduce health issues, however the effects on the infant’s long-term health have not been well understood, particularly in infants who exceed expectations and are born at term. The research suggests that many babies exposed to steroids avoid preterm birth, but new risks for other future health complications are introduced

Newswise: World Health Organization Includes the Cardiovascular Polypill in Its List of Essential Medicines After a Groundbreaking Study Led by the President of Mount Sinai Heart
Released: 2-Aug-2023 10:30 AM EDT
World Health Organization Includes the Cardiovascular Polypill in Its List of Essential Medicines After a Groundbreaking Study Led by the President of Mount Sinai Heart
Mount Sinai Health System

The cardiovascular polypill, developed by the Spanish National Centre for Cardiovascular Research (CNIC) and the pharmaceutical company Ferrer, has been included by the World Health Organization (WHO) in its List of Essential Medicines.

Released: 1-Aug-2023 4:05 PM EDT
Waters Launches XBridge Premier GTx BEH SEC Columns for Gene Therapy Applications
Waters Corporation

Waters Corporation (NYSE:WAT) introduced the first in a new line of size exclusion chromatography (SEC) columns aimed at improving the analysis while lowering the cost of gene therapies, specifically adeno-associated viral (AAV) vectors.

   
Newswise: New Study Sheds Light on the gating mechanism of Ion Channels
Released: 1-Aug-2023 8:10 AM EDT
New Study Sheds Light on the gating mechanism of Ion Channels
University of Vienna

Ion channels play a crucial role in many cellular processes, including neuronal communication, muscle contraction or cell proliferation. Most multi subunit ion channels exist in two functional states, either closed or open. During gating, one should expect that all subunits undergo conformational changes. The absence of intermediate conduction levels is surprising and asks for an explanation. A team of researchers from the University of Vienna and the Washington University in St. Louis created a smart model system to answer this important question. The study is currently published in Nature Communications.

   

Not for public release

This news release is embargoed until 31-Jul-2023 5:00 PM EDT Released to reporters: 25-Jul-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 31-Jul-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 31-Jul-2023 4:40 PM EDT
Oxycodone prescriptions after delivery not linked to longer-term opioid use compared to codeine prescriptions
Canadian Medical Association Journal

Postpartum prescriptions for oxycodone were not associated with increased risk of longer-term opioid use compared to codeine prescriptions, according to new research published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.221351.

Released: 31-Jul-2023 2:05 PM EDT
New process makes it easier to craft amino acids that don’t exist in nature
University of Pittsburgh

A team including University of Pittsburgh researchers uses computer modeling and new ways of employing enzymes to create never-before-seen amino acids.

Released: 28-Jul-2023 8:55 AM EDT
Targeting TAK1 protein to treat systemic sclerosis
Michigan Medicine - University of Michigan

Systemic sclerosis is the scaring of multiple organs within the body resulting in difficulty in functioning for these organs. The disease can become deadly if the organ scaring isn’t treated properly. Researchers at the University of Michigan Health System have identified a protein in the disease that may be a new target for treatment.

Released: 26-Jul-2023 5:30 PM EDT
NIH spent $950M for basic or applied research leading to patents providing market exclusivity for drugs approved 2010-19
Bentley University

A new demonstrates that the National Institutes of Health (NIH) spent $950 million on basic or applied research associated with patents that provided manufacturers with market exclusivity.

   
19-Jul-2023 10:00 AM EDT
Breaking Research on Advances in Drug Testing for Marijuana and Fentanyl
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

Two studies featured today at the 2023 AACC Annual Scientific Meeting & Clinical Lab Expo highlight advances that could boost the accuracy of marijuana tests and provide vital information for addressing the opioid epidemic.

Released: 26-Jul-2023 8:00 AM EDT
MD Anderson and Nexo Therapeutics announce strategic research collaboration to advance new therapies against intractable targets
University of Texas MD Anderson Cancer Center

MD Anderson and Nexo announced a strategic research collaboration to rapidly advance new cancer therapies against previously undruggable targets.

Released: 25-Jul-2023 5:40 PM EDT
Scientists may have discovered mechanism behind cognitive decline in aging
University of Colorado Anschutz Medical Campus

Scientists at the University of Colorado Anschutz Medical Campus have discovered what they believe to be the central mechanism behind cognitive decline associated with normal aging.

Newswise: Belly Fat Hinders Digestive Disease Medications
Released: 25-Jul-2023 1:50 PM EDT
Belly Fat Hinders Digestive Disease Medications
Cedars-Sinai

The mass and composition of our bodies can significantly affect the way medications are metabolized and absorbed. Investigators at Cedars-Sinai found that inflammatory bowel disease (IBD) patients with higher levels of intra-abdominal visceral adipose tissue– a distinctive type of fat inside the abdomen −had lower rates of remission when treated with certain anti-inflammatory medications.

Released: 25-Jul-2023 12:55 PM EDT
Researchers use Argonne X-rays to find the best antibodies
Argonne National Laboratory

Antibody therapies are only effective if the antibodies do what we want them to do. This research can help scientists determine if an antibody is likely to stick to something other than the intended target, which should lessen the amount of time wasted with overly sticky antibodies.

19-Jul-2023 10:00 AM EDT
ADLM Announces 2023 Top Corporate Supporter Award Recipients and Thanks Them for Invaluable Support
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

The Association for Diagnostics & Laboratory Medicine (ADLM) is pleased to announce the recipients of its 2023 Top Corporate Supporter Award.

Released: 25-Jul-2023 7:25 AM EDT
A Common Diabetes Drug Has a Surprising Side Gig: Muscle Protector
University of Utah Health

You might not think of diabetes when you think of muscle function. But a common diabetes drug that regulates blood sugar can also prevent muscle atrophy and muscular fibrosis—which can help the elderly bounce back faster from injury or illness.

Not for public release

This news release is embargoed until 24-Jul-2023 5:00 PM EDT Released to reporters: 18-Jul-2023 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 24-Jul-2023 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 24-Jul-2023 2:05 PM EDT
100-Year-Old Treatment Inhibits COVID-19 Infection
Rensselaer Polytechnic Institute (RPI)

A team of researchers led by Rensselaer Polytechnic Institute’s Jonathan S. Dordick, Ph.D., Institute Professor of Chemical and Biological Engineering, has illuminated a new possibility for the treatment and prevention of COVID-19 in research published in Communications Biology.

Released: 24-Jul-2023 12:05 PM EDT
Technology Developed at Rutgers Sublicensed to Global Biopharmaceutical Company
Rutgers University's Office for Research

Base editing technology invented at Rutgers, The State University of New Jersey, and exclusively licensed to Revvity, Inc. subsidiary Horizon Discovery, has been sub-licensed to biopharmaceutical company AstraZeneca to support its creation of cell therapies for the treatment of cancer and immune-mediated diseases.

19-Jul-2023 10:00 AM EDT
AACC Rebrands to the Association for Diagnostics & Laboratory Medicine
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

AACC, a global scientific and medical professional organization dedicated to better health through laboratory medicine, is pleased to announce a name change to the Association for Diagnostics & Laboratory Medicine.

Released: 21-Jul-2023 2:10 PM EDT
Bodybuilding Supplement May Help Stave off Alzheimer’s
RUSH

The secret to protecting your memory may be a staple of a bodybuilder’s diet. RUSH researchers recently discovered that a muscle-building supplement called beta-hydroxy beta-methylbutyrate, also called HMB, may help protect memory, reduce plaques and ultimately help prevent the progression of Alzheimer’s disease.

Released: 21-Jul-2023 10:25 AM EDT
Medication for abortion or miscarriage management unavailable at most Hamilton, Ontario pharmacies survey finds
McMaster University

A medication commonly used for abortion or miscarriage management is only available at six per cent of Hamilton, Ont. pharmacies, according to a McMaster University-led survey.



close
3.33872